Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,307.60
(
0.96%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.53
(
-0.67%
)
Bitcoin
78,022.68
(
-0.33%
)
News Focus
News Focus
Post# of 517558
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

FooBarAndGrill

Send PM Follow Ignore
Followers 46
Posts 3536
Boards Moderated 1
Alias Born 01/18/2016

FooBarAndGrill

Member Level

Re: meds4life post# 437065

Thursday, 10/26/2023 6:58:01 AM

Thursday, October 26, 2023 6:58:01 AM

Post# of 517558
Because Roche/Genentech recently reported a couple of flops in the Alz space: Gantenerumab & Crenezumab. However, at the moment, Roche is busy with the Telavant acquisition.

All my postings are verified and approved by my dog.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News